WuXi is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. The company offers global pharmaceutical and biotechnology companies an extensive portfolio of laboratory and manufacturing services varying from discovery chemistry to biological services and manufacturing of Application Programming Interfaces (APIs) for R&D.
The company provides cost-effective outsourcing solutions to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development. Its management team is comprised of Ph.D.s and MBAs with broad experience in drug R&D methodologies and Western-style business practices. The company’s senior management has more than 100 pending or granted patents, published over 500 publications and an average of 10 years of experience with working in major international pharmaceutical and biotechnology companies.
With over 1,300 scientific staff members, a 630,000 sq. ft. Shanghai Waigaoqiao Free Trade Zone research facility, a 220,000 sq. ft. cGMP-quality manufacturing plant, and a new 130,000 sq. ft. Tianjin research facility, WuXi PharmaTech is well-positioned to offer its customers high quality services.
Let us hear your thoughts below: